Elkaim, E. Et Al. 2016. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.. The Journal of allergy and clinical immunology , vol.138, no.1 .

Elkaim, E., Neven, B., Bruneau, J., Mitsui-Sekinaka, K., Stanislas, A., Heurtier, L., ... Lucas, C. L.(2016). Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.. The Journal of allergy and clinical immunology , vol.138, no.1.

Elkaim, Elodie Et Al. "Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.," The Journal of allergy and clinical immunology , vol.138, no.1, 2016

Elkaim, Elodie Et Al. "Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.." The Journal of allergy and clinical immunology , vol.138, no.1, 2016

Elkaim, E. Et Al. (2016) . "Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.." The Journal of allergy and clinical immunology , vol.138, no.1.

@article{article, author={Elodie Elkaim Et Al. }, title={Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.}, journal={The Journal of allergy and clinical immunology}, year=2016}